Maxion Therapeutics
Series ACambridge, UKMar 2025
Maxion Therapeutics raised €66M in a Series A round in Mar 2025. The company is based in Cambridge, UK. Investors in the round: BGF, British Patient Capital, Eli lilly and company and 4 others. Data as of Nov 2026.
Amount raised
€66M
€66,036,871
Native amount
72,000,000 USD
Stage
Series A
series a
Investors
7
Provenance & confidence
High confidenceAmount
72,000,000 USD
ECB-at-date → €66M · rate 1.0903 on 2025-03-17
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 namedBGFBritish Patient CapitalEli lilly and companyGeneral CatalystLifeArc VenturesMonograph CapitalSolasta Ventures
Date
Mar 2025
Round type
series a
Amount (EUR)
€66M
Other rounds
same companyRelated news
- Biotech Maxion Therapeutics secures £13m from investorsuktech.news · 2023-02
- tech.eu